Indocyanine green fluorescence imaging to evaluate graft perfusion during liver transplantation

Abstract

Background: Primary graft dysfunction (PGD) is a leading cause of graft loss after liver transplantation. There is no reliable method to anticipate this complication intraoperatively. Indocyanine green (ICG) fluorescence imaging is a technique used in hepatobiliary surgery for detection of liver malignancies, but has never been reported in the setting of liver transplantation (LT) for function assessment. We hypothesized that there could be an association between the type of fluorescence and the occurrence of PGD.

Methods: We retrospectively analyzed 72 patients who underwent LT at our center. An assessment of the liver graft with the ICG fluorescence technique was carried out. A classification comprising 3 types of fluorescence was created after evaluation of the recorded images. We assessed the relationship between the type of fluorescence and the occurrence of PGD.

Results: Crosstabulation analysis of the fluorescent types and occurrence of PGD yielded a statistically significant association (p = 0.002). Univariate analysis showed that an abnormal ICG fluorescence pattern was a risk factor for the occurrence of PGD after LT.

Conclusions: Our findings suggest that there could be an association between ICG fluorescence imaging and graft function. This intraoperative tool could be useful to detect patients at risk of developing PGD after LT.

Download full article

4 March 2025

×
×
Feedback

We use cookies

To optimize our website for you and to continuously improve it, we use cookies. Some cookies are necessary for the operation of the site, while others are used for anonymous statistical purposes or to enhance your user experience. You can decide for yourself which categories you want to allow. Please note that depending on your settings, not all features of the website may be available. Privacy policy

Disclaimer:

The content of this website is intended exclusively for healthcare professionals and is provided for informational purposes only. The information on this website does not replace professional medical advice, diagnosis, or treatment. EMIG GmbH assumes no responsibility for the timeliness, accuracy, or completeness of the information provided. The use of the content on this website is at the user’s own risk. EMIG GmbH reserves the right to modify, supplement, or delete parts of the pages or the entire content without prior notice. Links to external websites are provided solely for user convenience; EMIG GmbH assumes no responsibility for their content.